Enter your login e-mail to the account
Search
Search parameters
Search results
- Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- Sacituzumab govitekan – drug profile
MUDr. Branislav Bystrický, PhD., MPH
(3/2023, Drugs & drug classes ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(4/2012, Information & comments ) - The growth factors in oncology
MUDr. Ján Gyárfáš
(4/2012, Main topic ) - Capecitabine and its role in the treatment of advanced HER2 positive breast cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2011, Review articles ) - CARDIOVASCULAR COMPLICATIONS OF SELECTED ANTICANCER AGENTS – NEW INSIGHTS INTO PATHOGENESIS AND DIAGNOSTICS
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Silvia Cingelová
(2/2008, Review articles ) - Impact of CDK 4/6 inhibitors on overall survival of patients with advanced breast cancer – in the light of new data
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2024, Company information ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - An update in breast cancer treatment
MUDr. Markéta Palácová
(4/2007, Review articles ) - Anthracyclines in treating metastatic breast cancer
MUDr. Katarína Petráková
(3/2014, Review articles ) - LHRH analogs in treatment of breast cancer
MUDr. Ján Rajec, PhD., MUDr. Lucia Dzurillová
(3/2015, Review articles ) - Current position of vinorelbine within complex breast cancer treatment
MUDr. Silvia Jurišová, MUDr. Miroslava Malejčíková
(6/2016, Drugs & drug classes ) - Treatment of patients with HR+, HER2- PIK3CA-mutated advanced/metastatic breast cancer: results of trial SOLAR-1
MUDr. Andrej Rosík
(2/2021, Review articles ) - Inflammatory breast cancer
doc. MUDr. Mária Wagnerová, CSc.
(2/2012, Main topic ) - Significance of neoadjuvant treatment in patients with early breast cancer – perspective of surgeon
MUDr. Marián Karaba, prof. MUDr. Juraj Benca, PhD., MPH, MUDr. Terézia Lauková, doc. MUDr. Daniel Pinďák, PhD., MUDr. Dominika Rusnáková, MUDr. Martina Vranovská, MUDr. Otília Osifová
(2/2017, Review articles ) - Novinky zo San Antonio Breast Cancer Symposium
prof. MUDr. Stanislav Špánik, CSc., MUDr. Vladimír Malec, PhD., MUDr. Mária Rečková
(1/2013, Events ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Position of 4/6 cyclin-dependent kinase inhibitors in the 1st line of treatment of metastatic breast cancer
MUDr. Katarína Krajcsovics, PhD.
(4/2019, Review articles ) - Nano-particle nab-paclitaxel in treatment of metastatic breast cancer
MUDr. Jozef Dolinský, MUDr. Radovan Barilla, PhD.
(4/2011, Review articles ) - Publikujeme v zahraničí
(5/2011, Information & comments ) - Therapeutic procedures in the treatment of advanced triple-negative breast cancer – a nationwide survey among selected oncologists from oncology institutes and regional cancer centers in Slovakia
MUDr. Radovan Barila, PhD., MUDr. Elena Marušáková, MBA, Ing. Jan Žigmond
(3/2024, Review articles ) - Neratinib in treatment of HER2+ breast cancer – drug profile
MUDr. Radovan Barila, PhD.
(3/2020, Drugs & drug classes ) - Publikujeme v zahraničí
(4/2013, Information & comments ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Postavenie inhíbitorov aromatázy v adjuvantnej liečbe potmenopauzálnych žien s hormonálne pozitívnym karcinómom prsníka
MUDr. Jana Obertová
(2/2009, Review articles ) - Zriedkavé epitelové nádory prsníka
MUDr. Mária Rečková, PhD.
(3/2018, Main topic ) - Eribulin in treatment of breast cancer
doc. MUDr. Mária Wagnerová, CSc., MUDr. Hana Garanová
(1/2015, Drugs & drug classes ) - A comprehensive view of the treatment of HER2-positive breast cancer
MUDr. Bela Mriňáková, PhD., MPH
(2/2022, Main topic ) - Trastuzumab deruxtecan – drug profile and use in the treatment of advanced HER2-positive breast cancer
MUDr. Radovan Barila, PhD., MUDr. Lenka Svobodová, MUDr. Ján Bujňák, PhD.
(2/2022, Drugs & drug classes ) - THE INTRODUCTION TO INTERPRETATION OF CLINICAL TRIALS – Part II.
MUDr. Michal Mego, PhD., MUDr. Mária Rečková
(3/2008, Review articles ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - Targeted terapy of gastric cancer
MUDr. Vanda Ušáková, PhD.
(5/2014, Review articles ) - Publikujeme v zahraničí
(4/2016, Information & comments ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - Kam posunul trastuzumab deruxtecan liečbu HER2+ pozitívneho karcinómu prsníka?
MUDr. Miroslava Malejčíková
(2/2023, Review articles ) - CHEMOPREVENTION OF BREAST CANCER
prof. MUDr. Ľudovít M. Jurga, DrSc., prof. MUDr. Myrón Malý, CSc.
(5/2007, Review articles ) - Efficacy and cardiotoxicity risk of adjuvant treatment in HER2-positive patients with breast cancer
MUDr. Jaroslava Lešková
(1/2020, Review articles ) - Monoclonal antibodies in antitumorous therapy and infectious complications
MUDr. Ľuboš Drgoňa, CSc.
(6/2010, Review articles ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - Publikujeme v zahraničí
doc. MUDr. Michal Mego, PhD.
(6/2012, Information & comments ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - Abemaciclib in first-line treatment of HR+, HER2- breast cancer with visceral metastases in a premenopausal patient
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(3/2022, Case reports ) - Metronomic chemotherapy in breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2018, Review articles ) - Principles of hormonal therapy and chemotherapy in the treatment of metastatic HR+, HER2- breast cancer
MUDr. Miroslava Malejčíková
(6/2018, Review articles ) - NEOADJUVANT SYSTEMIC TREATMENT OF OPERABLE BREAST CANCER
prof. MUDr. Stanislav Špánik, CSc.
(3/2006, Review articles ) - SIGNIFICANCE OF GENE EXPRESSION PROFILING FOR PREDICTION OF PROGNOSIS AND THERAPY RESPONSE IN BREAST CARCINOMA
prof. MUDr. Lukáš Plank, CSc., doc. MUDr. Karol Kajo, PhD.
(4/2008, Review articles )